Aucta Pharmaceuticals Overview
- Year Founded
-
2012
- Status
-
IPO Registration
- Employees
-
184
- Latest Deal Type
-
IPO
- (Announced)
- Investors
-
14
Aucta Pharmaceuticals General Information
Description
Developer and provider of specialty pharmaceuticals and advanced drug delivery systems designed for central nervous system (CNS), respiratory, and ophthalmic therapeutic areas. The company provides integrated R&D, manufacturing, and commercialization services, enabling patients and healthcare providers with improved therapies through novel formulations, optimized dosing regimens, and new indications based on clinically validated molecules.
Contact Information
Website
www.auctapharma.comCorporate Office
- Building Number 10, Number 100 Banxia Road
- SIMZ Pudong
- Shanghai, 201318
- China
Corporate Office
- Building Number 10, Number 100 Banxia Road
- SIMZ Pudong
- Shanghai, 201318
- China
Aucta Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 12. IPO | 26-Jan-2026 | Announced | Generating Revenue | |||
| 11. Secondary Transaction - Private | 01-Dec-2025 | Completed | Generating Revenue | |||
| 10. Secondary Transaction - Private | 28-Sep-2022 | Completed | Generating Revenue | |||
| 9. Later Stage VC (Series C1) | 09-Oct-2021 | Completed | Generating Revenue | |||
| 8. Secondary Transaction - Private | 09-Oct-2021 | Completed | Generating Revenue | |||
| 7. Later Stage VC (Series C) | 30-Apr-2021 | Completed | Generating Revenue | |||
| 6. Later Stage VC (Series B2) | 31-Dec-2018 | Completed | Generating Revenue | |||
| 5. Later Stage VC (Series B1) | 31-Dec-2017 | Completed | Generating Revenue | |||
| 4. Accelerator/Incubator | 01-Jan-2016 | $4.86M | Completed | Generating Revenue | ||
| 3. Early Stage VC (Series A) | 03-Nov-2015 | $4.72M | $4.86M | Completed | Generating Revenue |
Aucta Pharmaceuticals Patents
Aucta Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-12478587-B1 | Formulation for lacosamide | Active | 06-Feb-2025 | ||
| EP-4789660-A1 | Novel formulation for lacosamide | Pending | 06-Feb-2025 | ||
| US-20260224500-A1 | Novel formulation for lacosamide | Pending | 06-Feb-2025 | ||
| US-20260207539-A1 | Pharmaceutical kit for preparation of ready-to-use vigabatrin solution | Pending | 21-Jan-2025 | ||
| EP-4635477-A1 | Composition containing lamotrigine, and preparation method and use thereof | Pending | 17-Apr-2024 | A61K9/14 |
Aucta Pharmaceuticals Signals
Aucta Pharmaceuticals Investors (14)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| DNV Capital | Venture Capital | Minority | ||
| Baopu Capital | Growth/Expansion | Minority | ||
| C&D Emerging Industry Equity Investment | Corporate Venture Capital | Minority | ||
| Hidea Venture Capital | Venture Capital | Minority | ||
| Beijing Zhengtai Sunshine Equity Investment Fund Management | Growth/Expansion | Minority |
Aucta Pharmaceuticals FAQs
-
When was Aucta Pharmaceuticals founded?
Aucta Pharmaceuticals was founded in 2012.
-
Where is Aucta Pharmaceuticals headquartered?
Aucta Pharmaceuticals is headquartered in Shanghai, China.
-
What is the size of Aucta Pharmaceuticals?
Aucta Pharmaceuticals has 184 total employees.
-
What industry is Aucta Pharmaceuticals in?
Aucta Pharmaceuticals’s primary industry is Pharmaceuticals.
-
Is Aucta Pharmaceuticals a private or public company?
Aucta Pharmaceuticals is a Private company.
-
What is Aucta Pharmaceuticals’s current revenue?
The current revenue for Aucta Pharmaceuticals is .
-
How much funding has Aucta Pharmaceuticals raised over time?
Aucta Pharmaceuticals has raised $68.6M.
-
Who are Aucta Pharmaceuticals’s investors?
DNV Capital, Baopu Capital, C&D Emerging Industry Equity Investment, Hidea Venture Capital, and Beijing Zhengtai Sunshine Equity Investment Fund Management are 5 of 14 investors who have invested in Aucta Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process